Exclusive Summary

• Seize the imminent patent cliff window through an out-licensing model, empowering overseas clients to achieve first-to-file registration or Day-1 commercial launch.
• Target a massive global market addressing millions of patients, providing an indispensable, authoritative guideline-recommended first-line standard-of-care therapy.
• Deliver robust tender and pricing competitiveness leveraging international quality certifications and the extraordinary cost efficiency of vertically integrated API-to-FDF manufacturing.

Asset Materials

Contact Us for Full Materials